Crigler-Najjar Syndrome
11 clinical trials · Condition
◉ Watch Crigler-Najjar Syndrome
| Record | Firm | Date |
|---|---|---|
| HepaStem Long-Term Safety Registry (NCT03343756) | Cellaion SA | 2018-04-04 |
| Gene Therapy for Severe Crigler Najjar Syndrome (NCT03466463) | Genethon | 2018-03-19 |
| Gene Transfer Clinical Study in Crigler-Najjar Syndrome (NCT03223194) | Audentes Therapeutics | 2017-09-08 |
| Clinical Assessment Study in Crigler-Najjar Syndrome (NCT03078881) | Audentes Therapeutics | 2017-03-10 |
| New Phototherapy Device to Treat Patients With Crigler-Najjar Disease (NCT02356978) | Assistance Publique - Hôpitaux de Paris | 2014-12-01 |
| Immunity Against AAV in Crigler Najjar Patient (NCT02302690) | Genethon | 2014-11-01 |
| Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001) (NCT02051049) | Cellaion SA | 2013-03-01 |
| Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN) (NCT01765283) | Cellaion SA | 2012-03-01 |
| Orlistat Treatment of Crigler-Najjar Disease (NCT00461799) | University Medical Center Groningen | 2003-09-01 |
Track Crigler-Najjar Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.